Breaking with Tradition
Can immunophenotyping challenge classical approaches to cytology?
Areej Khatib |
In my view, a profession is an accumulation of knowledge and experience, affected by one’s personality and background. Many describe me as being “different” and this quality has accompanied me ever since I began my independent pathology practice. And perhaps it’s the reason why I challenge classical approaches to cytology.
For example, take the investigation of malignancy versus benignancy by means of the cytology of body effusions. There have been few innovations in this field since Muller laid the foundations of clinical cytology as we know it today in 1838 (1). Even with Papanicolaou’s great discovery of his famous “Pap test” in 1928, much remained the same, and those pathologists that followed him added little to classical cytology practice (2).
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.